The purpose of the present invention is to provide a technique for achieving a clear appearance in an ophthalmic composition which is for a zwitterionic soft contact lens (SCL) and which contains pranoprofen and/or a salt thereof and inhibiting the pranoprofen and/or the salt thereof from being adsorbed on the SCL. The technique includes: adding chondroithin sulfate and/or a salt thereof to an ophthalmic composition which is for a zwitterionic SCL and which contains pranoprofen and/or a salt thereof and adjusting the pH of the composition to 5.5 or higher. The technique can achieve a clear appearance in the ophthalmic composition and effectively inhibit the pranoprofen and/or the salt thereof from being adsorbed on the SCL.
